Corindus Vascular Robotics (Waltham, Massachusetts) said it has gained $26.6 million from selling shares of its common stock to accredited investors.

The developer of precision vascular robotics had issued the 10,666,570 shares in a private placement for a purchase price of $2.50 per share. Cowen and Company, and Stifel, Nicolaus & Company, acted as placement agents for the company during the transfer.

The company said it planned to use the funding to expand its sales team and product commercialization, while reinvesting in its product line.

In other financings activity: RightCare (Horsham, Pennsylvania), a medical technology company focused on improving patient outcomes and reducing readmissions, said it has secured $4 million in additional capital from NewSpring Health Capital, the dedicated healthcare fund of NewSpring Capital of Radnor, Pennsylvania. Additionally, NewSpring Capital's General Partner, Brian Murphy, will join RightCare's board.

The additional capital will be used to further accelerate and broaden the commercial growth of RightCare's software through geographic expansion across the nation, and continue with ongoing product innovation to support the increasing market needs of its hospital, health system, and post-acute care provider partners.